These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10368873)

  • 61. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.
    Bull EJ; Hutson PH; Fone KC
    Neuropharmacology; 2004 Feb; 46(2):202-10. PubMed ID: 14680758
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Party people: personality and MDMA use of house party visitors.
    ter Bogt TF; Engels RC; Dubas JS
    Addict Behav; 2006 Jul; 31(7):1240-4. PubMed ID: 16143453
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
    Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
    Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infection.
    Nelson DA; Singh SJ; Young AB; Tolbert MD; Bost KL
    Drug Alcohol Depend; 2011 Jul; 116(1-3):211-21. PubMed ID: 21269783
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice.
    Daza-Losada M; Ribeiro Do Couto B; Manzanedo C; Aguilar MA; Rodríguez-Arias M; Miñarro J
    Neuropsychopharmacology; 2007 Aug; 32(8):1750-9. PubMed ID: 17299518
    [TBL] [Abstract][Full Text] [Related]  

  • 67. DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations.
    Frenzilli G; Ferrucci M; Giorgi FS; Blandini F; Nigro M; Ruggieri S; Murri L; Paparelli A; Fornai F
    Behav Pharmacol; 2007 Sep; 18(5-6):471-81. PubMed ID: 17762515
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
    Hanson KL; Luciana M
    J Clin Exp Neuropsychol; 2010 Apr; 32(4):337-49. PubMed ID: 20397296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors.
    Bankson MG; Cunningham KA
    Neuropsychopharmacology; 2002 Jan; 26(1):40-52. PubMed ID: 11751031
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in the structure of the agonistic behavior of mice produced by D-amphetamine.
    Moro M; Salvador A; Simón VM
    Pharmacol Biochem Behav; 1997 Jan; 56(1):47-54. PubMed ID: 8981608
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Experience-dependent changes in temperature and behavioral activity induced by MDMA.
    Reveron ME; Maier EY; Duvauchelle CL
    Physiol Behav; 2006 Oct; 89(3):358-63. PubMed ID: 16876209
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration.
    Bird J; Schenk S
    Addict Biol; 2013 Jul; 18(4):654-64. PubMed ID: 22784256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of group exposure on single injection-induced behavioral sensitization to drugs of abuse in mice.
    Procópio-Souza R; Fukushiro DF; Trombin TF; Wuo-Silva R; Zanlorenci LH; Lima AJ; Ribeiro LT; Corrêa JM; Marinho EA; Kameda SR; Andersen ML; Tufik S; Frussa-Filho R
    Drug Alcohol Depend; 2011 Nov; 118(2-3):349-59. PubMed ID: 21596493
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or 'ecstasy' and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices.
    Kamboj SK; Kilford EJ; Minchin S; Moss A; Lawn W; Das RK; Falconer CJ; Gilbert P; Curran HV; Freeman TP
    J Psychopharmacol; 2015 Sep; 29(9):961-70. PubMed ID: 25990558
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA).
    Young R; Khorana N; Bondareva T; Glennon RA
    Pharmacol Biochem Behav; 2005 Oct; 82(2):404-10. PubMed ID: 16253319
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.
    Cami J; Farré M; Mas M; Roset PN; Poudevida S; Mas A; San L; de la Torre R
    J Clin Psychopharmacol; 2000 Aug; 20(4):455-66. PubMed ID: 10917407
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors.
    Reinhard C; Wolffgramm J
    Addict Biol; 2006 Jun; 11(2):131-44. PubMed ID: 16800826
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.
    Huether G; Zhou D; Rüther E
    J Neural Transm (Vienna); 1997; 104(8-9):771-94. PubMed ID: 9451711
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intimate insight: MDMA changes how people talk about significant others.
    Baggott MJ; Kirkpatrick MG; Bedi G; de Wit H
    J Psychopharmacol; 2015 Jun; 29(6):669-77. PubMed ID: 25922420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.